| Aktie | Ticker | 2026/Q1 | 2025/Q4 | ||||
|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | ||
| 415.936.109 $ | +205.830.107 $ | +157,3 % | 302.659.606 $ | +302.659.606 $ | |||
| Cidara Therapeutics, Inc. | 51.305.899 $ | +51.305.899 $ | |||||
| RELMADA THERAPEUTICS, INC. | RLMD | 42.998.208 $ | +23.261.954 $ | +117,9 % | 19.736.254 $ | +19.736.254 $ | |
| BANK OF AMERICA CORP /DE/ | BAC | 36.645.183 $ | +18.702.175 $ | +104,2 % | 17.943.008 $ | +17.943.008 $ | |
| LB PHARMACEUTICALS INC | LBRX | 33.644.866 $ | +11.260.366 $ | +50,3 % | 22.384.500 $ | +22.384.500 $ | |
| Dianthus Therapeutics, Inc. /DE/ | DNTH | 31.325.154 $ | +19.067.775 $ | +155,6 % | 12.257.379 $ | +12.257.379 $ | |
| Relay Therapeutics, Inc. | RLAY | 29.692.044 $ | +4.446.346 $ | +17,6 % | 25.245.698 $ | +25.245.698 $ | |
| Alto Neuroscience, Inc. | ANRO | 29.116.321 $ | +25.149.698 $ | +634,0 % | 3.966.623 $ | +3.966.623 $ | |
| Centessa Pharmaceuticals plc | CNTA | 19.456.802 $ | +17.506.097 $ | +897,4 % | 1.950.705 $ | +1.950.705 $ | |
| Vaxcyte, Inc. | PCVX | 14.278.150 $ | -4.194.460 $ | -22,7 % | 18.472.610 $ | +18.472.610 $ | |
| Savara Inc | SVRA | 18.472.136 $ | +3.933.245 $ | +27,1 % | 14.538.891 $ | +14.538.891 $ | |
| KalVista Pharmaceuticals, Inc. | KALV | 18.070.319 $ | +11.804.636 $ | +188,4 % | 6.265.683 $ | +6.265.683 $ | |
| EyePoint, Inc. | EYPT | 17.932.791 $ | +17.932.791 $ | ||||
| Erasca, Inc. | ERAS | 6.836.746 $ | -7.632.685 $ | -52,8 % | 14.469.431 $ | +14.469.431 $ | |
| Enliven Therapeutics, Inc. | ELVN | 12.897.035 $ | +6.027.341 $ | +87,7 % | 6.869.694 $ | +6.869.694 $ | |
| Eikon Therapeutics, Inc. | EIKN | 12.585.325 $ | +2.821.221 $ | +28,9 % | 9.764.104 $ | +9.764.104 $ | |
| ENANTA PHARMACEUTICALS INC | ENTA | 11.778.713 $ | +5.633.349 $ | +91,7 % | 6.145.364 $ | +6.145.364 $ | |
| Alkermes plc. | ALKS | 11.244.197 $ | +11.244.197 $ | ||||
| Perspective Therapeutics, Inc. | CATX | 10.955.036 $ | +10.955.036 $ | ||||
| Minerva Neurosciences, Inc. | NERV | 9.974.388 $ | +3.319.278 $ | +49,9 % | 6.655.110 $ | +6.655.110 $ | |
| OCULAR THERAPEUTIX, INC | OCUL | 9.517.748 $ | +9.517.748 $ | ||||
| Century Therapeutics, Inc. | IPSC | 9.173.462 $ | +7.759.322 $ | +548,7 % | 1.414.140 $ | +1.414.140 $ | |
| ALUMIS INC. | ALMS | 8.648.405 $ | +8.648.405 $ | ||||
| SAB Biotherapeutics, Inc. | SABS | 8.420.263 $ | +197.866 $ | +2,4 % | 8.222.397 $ | +8.222.397 $ | |
| Inhibikase Therapeutics, Inc. | IKT | 6.017.093 $ | -1.325.193 $ | -18,0 % | 7.342.286 $ | +7.342.286 $ | |
| Abivax S.A. | ABVX | 6.623.943 $ | +6.623.943 $ | ||||
| CYBIN INC. | HELP | 6.298.600 $ | +6.298.600 $ | ||||
| Maze Therapeutics, Inc. | MAZE | 5.970.000 $ | +5.970.000 $ | ||||
| AN2 Therapeutics, Inc. | ANTX | 5.575.870 $ | +5.575.870 $ | ||||
| Lexeo Therapeutics, Inc. | LXEO | 5.330.124 $ | +3.592.374 $ | +206,7 % | 1.737.750 $ | +1.737.750 $ | |
| Helix Acquisition Corp. III | HLXC | 5.080.000 $ | +5.080.000 $ | ||||
| Alector, Inc. | ALEC | 4.517.296 $ | +2.773.238 $ | +159,0 % | 1.744.058 $ | +1.744.058 $ | |
| LeonaBio, Inc. | LONA | 3.844.884 $ | +864.567 $ | +29,0 % | 2.980.317 $ | +2.980.317 $ | |
| Corvus Pharmaceuticals, Inc. | CRVS | 3.388.089 $ | +3.388.089 $ | ||||
| SUTRO BIOPHARMA, INC. | STRO | 874.623 $ | +874.623 $ | ||||
| 415.936.109 $ | +205.830.107 $ | +157,3 % | 302.659.606 $ | +302.659.606 $ | |||